致编辑的信：2019冠状病毒病和糖尿病酮症酸中毒患者意外的高死亡率 - Suppr

Letter to the editor: Unexpected high mortality in COVID-19 and diabetic ketoacidosis.

作者信息

Chamorro-Pareja Natalia, Parthasarathy Sahana, Annam Jayabhargav, Hoffman Julie, Coyle Christine, Kishore Preeti

机构信息

Department of Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States of America.

Division of Infectious Diseases, Department of Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States of America.

出版信息

Metabolism. 2020 Sep;110:154301. doi: 10.1016/j.metabol.2020.154301. Epub 2020 Jun 24.

DOI:10.1016/j.metabol.2020.154301

PMID:32589899

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7311346/

Abstract

摘要

相似文献

Letter to the editor: Unexpected high mortality in COVID-19 and diabetic ketoacidosis.

Metabolism. 2020 Sep;110:154301. doi: 10.1016/j.metabol.2020.154301. Epub 2020 Jun 24.

Reply to comments on Letter to the Editor - Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.

Diabetes Res Clin Pract. 2020 Aug;166:108305. doi: 10.1016/j.diabres.2020.108305. Epub 2020 Jul 3.

Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.

Diabetes Res Clin Pract. 2020 Aug;166:108279. doi: 10.1016/j.diabres.2020.108279. Epub 2020 Jun 25.

Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection.

Metabolism. 2020 Jul;108:154255. doi: 10.1016/j.metabol.2020.154255. Epub 2020 Apr 29.

Letter to the Editor: Two Perspectives on the COVID-19 Pandemic Nobody Is Talking About-and It's Costing Lives.

World Neurosurg. 2020 Jul;139:723. doi: 10.1016/j.wneu.2020.05.004. Epub 2020 May 18.

Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.

J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa360.

Denominator matters in estimating COVID-19 mortality rates.

Eur Heart J. 2020 Oct 1;41(37):3500. doi: 10.1093/eurheartj/ehaa282.

SARS-CoV-2 viral load predicts COVID-19 mortality.

Lancet Respir Med. 2020 Sep;8(9):e70. doi: 10.1016/S2213-2600(20)30354-4. Epub 2020 Aug 6.

The battle against COVID-19: mortality in Italy.

Eur Heart J. 2020 Jun 7;41(22):2050-2052. doi: 10.1093/eurheartj/ehaa326.

Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care.

Crit Care. 2020 Nov 6;24(1):639. doi: 10.1186/s13054-020-03362-y.

引用本文的文献

Inflammatory biomarkers predict higher risk of hyperglycemic crises but not outcomes in diabetic patients with COVID-19.

Front Endocrinol (Lausanne). 2024 Feb 15;15:1287795. doi: 10.3389/fendo.2024.1287795. eCollection 2024.

Clinical profile and outcome of critically ill COVID-19 patients with diabetic ketoacidosis: A single-centre cross-sectional study in South India.

Indian J Anaesth. 2023 Mar;67(3):309-313. doi: 10.4103/ija.ija_368_22. Epub 2023 Mar 16.

Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature review.

J Diabetes Metab Disord. 2023 Apr 8;22(1):135-146. doi: 10.1007/s40200-023-01207-3. eCollection 2023 Jun.

Cureus. 2023 Mar 25;15(3):e36674. doi: 10.7759/cureus.36674. eCollection 2023 Mar.

Insulin Requirements for Patients With COVID-19 Presenting With Diabetic Ketoacidosis.

Cureus. 2023 Jan 2;15(1):e33258. doi: 10.7759/cureus.33258. eCollection 2023 Jan.

Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies.

Front Endocrinol (Lausanne). 2022 Aug 10;13:983206. doi: 10.3389/fendo.2022.983206. eCollection 2022.

Clinical Profile and Outcomes of Diabetic Ketoacidosis during the COVID-19 Pandemic in North India.

Trop Doct. 2022 Jul;52(3):375-381. doi: 10.1177/00494755221076896. Epub 2022 Mar 18.

The impact of COVID-19 on Diabetic Ketoacidosis patients.

Diabetes Metab Syndr. 2022 Jan;16(1):102389. doi: 10.1016/j.dsx.2022.102389. Epub 2022 Jan 7.

Diabetic ketoacidosis and high mortality among patients with coronavirus disease 2019 in a Peruvian hospital.

J Diabetes Investig. 2022 Apr;13(4):746-748. doi: 10.1111/jdi.13704. Epub 2021 Nov 23.

Diabetic ketoacidosis and COVID-19: what have we learned so far?

Am J Physiol Endocrinol Metab. 2022 Jan 1;322(1):E44-E53. doi: 10.1152/ajpendo.00244.2021. Epub 2021 Nov 15.

本文引用的文献

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.

Metabolism. 2020 Jul;108:154262. doi: 10.1016/j.metabol.2020.154262. Epub 2020 May 16.

Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs.

JAMA. 2020 Jun 2;323(21):2192-2195. doi: 10.1001/jama.2020.7197.

Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.

Metabolism. 2020 Jun;107:154245. doi: 10.1016/j.metabol.2020.154245. Epub 2020 Apr 19.

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.

COVID-19 infection may cause ketosis and ketoacidosis.

Diabetes Obes Metab. 2020 Oct;22(10):1935-1941. doi: 10.1111/dom.14057. Epub 2020 May 18.

The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities.

J Racial Ethn Health Disparities. 2020 Jun;7(3):398-402. doi: 10.1007/s40615-020-00756-0. Epub 2020 Apr 18.

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.

J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.

Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.

Metabolism. 2020 Jul;108:154224. doi: 10.1016/j.metabol.2020.154224. Epub 2020 Apr 7.

COVID-19 pandemic, coronaviruses, and diabetes mellitus.

Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741. doi: 10.1152/ajpendo.00124.2020. Epub 2020 Mar 31.

Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.

Metabolism. 2020 Jun;107:154216. doi: 10.1016/j.metabol.2020.154216. Epub 2020 Mar 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Letter to the editor: Unexpected high mortality in COVID-19 and diabetic ketoacidosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献